Choosing a drug manufacturing site based on a product's point in the life cycle benefits patients, first by enabling rapid, reliable access to new therapeutics, and later by driving down the cost of mature products.

Why Do Integrated Services Matter?

SPONSORED BY:

Free Download
In the initial days of integrated services, CDMOs were primarily geared toward early-stage development, helping clients obtain an investigational new drug (IND) application. Today, however, integrated CDMOs like Piramal Pharma Solutions assist companies across the entire development process, including late stage and commercial projects.

From discovery to intermediates, active pharmaceutical ingredients (APIs) and drug products, a CDMO requires expertise across multiple elements of the pharma process to deliver an integrated experience. Through comprehensive project management teams, PPS oversees and executes all elements of this work on behalf of its clients and their patients. By taking ownership of the end-to-end integrated project, we gain in speed while also de-risking transfers between multiple CDMOs.


Free Download
Other Available Whitepapers

Deploying Bioavailability Enhancement Techniques to Improve Patients' Lives
Oral bioavailability is a constant challenge for developers of new chemical entities. Low solubility and permeability often reduce the fraction of an orally administered drug absorbed in the bloodstream. Increasing the dose to have adequate circulating drug at the intended site of action may not always be a feasible option. As such, drug developers need ways to improve the bioavailability of their molecules.


Eastern & Western Manufacturig Solutions for Late Life Cycle Products
Choosing a drug manufacturing site based on a product's point in the life cycle benefits patients, first by enabling rapid, reliable access to new therapeutics, and later by driving down the cost of mature products. The challenge is to find production sites that cater to both the specific priorities faced at different points in the life cycle and the universal requirements that apply to all products at all times.


PATIENT CENTRICITY: A compassionate approach that puts patients at the forefront of our mission.
Embracing a patient-focused ideology represents a massive change for a CDMO. In this white paper, we take an in-depth look at what Patient Centricity means, how it is driving organizational development, and its effect on employee awareness of how our work impacts lives.




This email was sent to you by Contract Pharma Magazine.

You are receiving this message because you opted in at contractpharma.com. To change your preferences or unsubscribe please use the links below.

To ensure delivery and proper display of your emails, please add our email address (cp@email.contractpharma.com) to your address book and if needed enable images in your email client.

To update your user profile please click here.

To unsubscribe or change your email subscription preferences please click here.

If you are having trouble with receiving Contract Pharma Magazine or would like to receive it, click here.

Advertise with us

Our mailing address is:

Contract Pharma
Rodman Media
25 Philips Parkway, Montvale, NJ 07645 USA
Tel: 201-825-2552, Fax: 201-825-0553

© Copyright 2021 Contract Pharma All rights reserved.